Practical considerations in the management of hand-foot skin reaction caused by multikinase inhibitors

Laura S. Wood; Harvey Lemont; Aminah Jatoi; Mario E. Lacouture; Caroline Robert; Karen Keating; Roger Anderson

doi:10.1016/S1548-5315(11)70385-0

Practical considerations in the management of hand-foot skin reaction caused by multikinase inhibitors

Laura S. Wood, Harvey Lemont, Aminah Jatoi, Mario E. Lacouture, Caroline Robert, Karen Keating, Roger Anderson

Medical Oncology

Research output: Contribution to journal › Article › peer-review

17 Scopus citations

Abstract

Multikinase inhibitors (MKIs, eg, sorafenib and sunitinib) are oral anticancer agents associated with handfoot skin reaction (HFSR), a cutaneous adverse event affecting 20%-40% of patients treated with these drugs. Although usually mild, symptoms of HFSR can evolve into a painful condition, resulting in a shortened duration or intensity of cancer treatment. An international, interdisciplinary panel of experts recently provided the first consensus recommendations for the management of MKI-associated HFSR.

Original language	English (US)
Pages (from-to)	23-29
Number of pages	7
Journal	Community Oncology
Volume	7
Issue number	1
DOIs	https://doi.org/10.1016/S1548-5315(11)70385-0
State	Published - Jan 2010

ASJC Scopus subject areas

Hematology
Oncology

Access to Document

10.1016/S1548-5315(11)70385-0

Cite this

@article{348aacce36b3481791c47841db7a9669,

title = "Practical considerations in the management of hand-foot skin reaction caused by multikinase inhibitors",

abstract = "Multikinase inhibitors (MKIs, eg, sorafenib and sunitinib) are oral anticancer agents associated with handfoot skin reaction (HFSR), a cutaneous adverse event affecting 20%-40% of patients treated with these drugs. Although usually mild, symptoms of HFSR can evolve into a painful condition, resulting in a shortened duration or intensity of cancer treatment. An international, interdisciplinary panel of experts recently provided the first consensus recommendations for the management of MKI-associated HFSR.",

author = "Wood, {Laura S.} and Harvey Lemont and Aminah Jatoi and Lacouture, {Mario E.} and Caroline Robert and Karen Keating and Roger Anderson",

year = "2010",

month = jan,

doi = "10.1016/S1548-5315(11)70385-0",

language = "English (US)",

volume = "7",

pages = "23--29",

journal = "Community Oncology",

issn = "1548-5315",

publisher = "BioLink Communications",

number = "1",

}

TY - JOUR

T1 - Practical considerations in the management of hand-foot skin reaction caused by multikinase inhibitors

AU - Wood, Laura S.

AU - Lemont, Harvey

AU - Jatoi, Aminah

AU - Lacouture, Mario E.

AU - Robert, Caroline

AU - Keating, Karen

AU - Anderson, Roger

PY - 2010/1

Y1 - 2010/1

N2 - Multikinase inhibitors (MKIs, eg, sorafenib and sunitinib) are oral anticancer agents associated with handfoot skin reaction (HFSR), a cutaneous adverse event affecting 20%-40% of patients treated with these drugs. Although usually mild, symptoms of HFSR can evolve into a painful condition, resulting in a shortened duration or intensity of cancer treatment. An international, interdisciplinary panel of experts recently provided the first consensus recommendations for the management of MKI-associated HFSR.

AB - Multikinase inhibitors (MKIs, eg, sorafenib and sunitinib) are oral anticancer agents associated with handfoot skin reaction (HFSR), a cutaneous adverse event affecting 20%-40% of patients treated with these drugs. Although usually mild, symptoms of HFSR can evolve into a painful condition, resulting in a shortened duration or intensity of cancer treatment. An international, interdisciplinary panel of experts recently provided the first consensus recommendations for the management of MKI-associated HFSR.

UR - http://www.scopus.com/inward/record.url?scp=77649213517&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77649213517&partnerID=8YFLogxK

U2 - 10.1016/S1548-5315(11)70385-0

DO - 10.1016/S1548-5315(11)70385-0

M3 - Article

AN - SCOPUS:77649213517

SN - 1548-5315

VL - 7

SP - 23

EP - 29

JO - Community Oncology

JF - Community Oncology

IS - 1

ER -

Practical considerations in the management of hand-foot skin reaction caused by multikinase inhibitors

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this